Klaus Willenbrock
- Pathology and Forensic Medicine top 2%
- Oncology top 5%
- Immunology top 10%
- Genetics top 5%
- Molecular Biology
- Co-authors
- Martin‐Leo HansmannAndreas BräuningerRalf KüppersChristoph RennéKlaus RajewskyAnja MottokHans‐Heinrich WackerPhilippe Gaulard
- Topics
- Lymphoma Diagnosis and Treatment (19 papers)Chronic Lymphocytic Leukemia Research (8 papers)Cutaneous lymphoproliferative disorders research (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Klaus Willenbrock
23 papers receiving 857 citations
Peers
Comparison fields: 5 of 54
- Pathology and Forensic Medicine 558
- Oncology 465
- Immunology 291
- Genetics 198
- Molecular Biology 148
Countries citing papers authored by Klaus Willenbrock
This map shows the geographic impact of Klaus Willenbrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Willenbrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Willenbrock more than expected).
Fields of papers citing papers by Klaus Willenbrock
This network shows the impact of papers produced by Klaus Willenbrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Willenbrock. The network helps show where Klaus Willenbrock may publish in the future.
Co-authorship network of co-authors of Klaus Willenbrock
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Willenbrock. A scholar is included among the top collaborators of Klaus Willenbrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Willenbrock. Klaus Willenbrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 58 | |
| 2 | 18 | |
| 3 | 99 | |
| 4 | 2 | |
| 5 | 77 | |
| 6 | 45 | |
| 7 | 90 | |
| 8 | Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. | 50 |
| 9 | 51 | |
| 10 | 26 | |
| 11 | 96 | |
| 12 | 21 | |
| 13 | 6 | |
| 14 | [Pathology of Hodgkin's lymphoma]. | 2 |
| 15 | 27 | |
| 16 | 11 | |
| 17 | 13 | |
| 18 | 32 | |
| 19 | 95 | |
| 20 | 19 |
About Klaus Willenbrock
Klaus Willenbrock is a scholar working on Pathology and Forensic Medicine, Genetics and Dermatology, having authored 23 papers that have together received 874 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Cutaneous lymphoproliferative disorders research (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (558 citations), Genetics (198 citations) and Oncology (465 citations). Klaus Willenbrock has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Martin‐Leo Hansmann, Andreas Bräuninger, Ralf Küppers, Christoph Renné, Klaus Rajewsky, Anja Mottok, Hans‐Heinrich Wacker, Philippe Gaulard, Berit Jungnickel and Verena Brune. Their work appears in journals such as The Journal of Experimental Medicine, Blood and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.